Office of Research & Development |
|
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I21RX003323-01 |
| Title: | TTI-0102, a Cysteamine Precursor for Mild to Moderate TBI: Dosing and Feasibility Study |
| Principal Investigator: | Elizabeth Twamley |
| Location: | San Diego, CA |
| Congressional District Code: | 52 |
| Research Service: | Rehabilitation R&D |
| Project Period: | April 2020 - March 2022 |
| FY 2021 Funding Amount: | $66,087 |
| Total Award Amount (all years): |
$143,228 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Approximately 12-23% of returning service members report a history of traumatic brain injury, mostly mild (mTBI). Post-concussive symptoms such as memory problems, irritability, and difficulty concentrating are common after TBI and may become chronic, interfering with successful return to duty or civilian reintegration, reducing quality of life, and increasing health care utilization for Veterans. In those whose TBI-related symptoms persist, there is accumulating evidence for increased morbidity... |